---
layout: post
title: "Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act; Guidance for Industry; Availability"
date: 2026-02-05 18:56:40 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-18831
original_published: 2023-08-31 00:00:00 +0000
significance: 8.00
---

# Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act; Guidance for Industry; Availability

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** August 31, 2023 00:00 UTC
**Document Number:** 2023-18831

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act." This guidance clarifies the enhanced drug distribution security requirements listed in the Federal Food, Drug, and Cosmetic Act (FD&C Act). In addition, this guidance outlines and makes recommendations on the system attributes necessary to enable secure tracing of product at the package level, including allowing for the use of verification, inference, and aggregation, as necessary. This guidance finalizes the draft guidance of the same title issued on June 4, 2021.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/08/31/2023-18831/enhanced-drug-distribution-security-at-the-package-level-under-the-drug-supply-chain-security-act)
- API: https://www.federalregister.gov/api/v1/documents/2023-18831

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
